Fluorometric determination of total retinyl esters in triglyceride-rich lipoproteins

被引:0
|
作者
Orth, M
Hanisch, M
Kröning, G
Porsch-Özcürümez, M
Wieland, H
Luley, C
机构
[1] Klinikum Otto Von Guericke Univ, Inst Klin Chem, D-39120 Magdeburg, Germany
[2] Univ Freiburg, Klin Chem Abt, D-79106 Freiburg, Germany
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A time-consuming sample preparation and measuring procedure is required for the quantitation of retinyl palmitate by HPLC. We developed a fluorometric method for the determination of total retinyl esters in chylomicrons, chylomicron remnants, and VLDL. This method is precise, sensitive, rapid, simple, and particularly useful for large-scale studies of postprandial lipid metabolism. Because the turbidity of postprandial lipemic samples interferes with the fluorescence measurement, all samples were incubated for 10 min with a clearing buffer containing esterase and detergents. This buffer eliminates the turbidity and hydrolyzes all retinyl esters to retinol. The fluorescence signal (excitation wavelength, 330 nm; emission wavelength, 490 nm) was linear from 0.1 mg/L up to 4 mg/L retinyl palmitate, and the CVs were 3.6% within-run and 5.1% within-series. A first application studied postprandial lipoproteins, which were first separated by ultracentrifugation and then subjected to size exclusion chromatography. Fluorescence analysis revealed that the chylomicron density fraction contains large amounts of chylomicron remnants.
引用
收藏
页码:1459 / 1465
页数:7
相关论文
共 50 条
  • [31] Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
    Jan Borén
    Marja-Riitta Taskinen
    Elias Björnson
    Chris J. Packard
    Nature Reviews Cardiology, 2022, 19 : 577 - 592
  • [32] Heterogeneity of triglyceride-rich lipoproteins in the postprandial state
    Karpe, F
    INSULIN RESISTANCE, METABOLIC DISEASES AND DIABETIC COMPLICATIONS, 1999, 1177 : 143 - 146
  • [33] Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
    Geesje M. Dallinga-Thie
    Jeffrey Kroon
    Jan Borén
    M. John Chapman
    Current Cardiology Reports, 2016, 18
  • [34] Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
    Boren, Jan
    Taskinen, Marja-Riitta
    Bjornson, Elias
    Packard, Chris J.
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (09) : 577 - 592
  • [35] DETECTION OF ENDOTOXIN IN TRIGLYCERIDE-RICH LIPOPROTEINS INVITRO
    HARRIS, HW
    EICHBAUM, EB
    KANE, JP
    RAPP, JH
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1991, 118 (02): : 186 - 193
  • [36] FAMILIAL HYPERLIPOPROTEINEMIAS AND THE METABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS
    BRUNZELL, JD
    TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH, 1989, 14 (06): : 174 - 176
  • [37] Role of Triglyceride-Rich Lipoproteins in Renal Injury
    Ng, Kit Fai
    Aung, Hnin Hnin
    Rutledge, John C.
    DIABETES AND THE KIDNEY, 2011, 170 : 165 - 171
  • [38] Triglyceride-Rich Lipoproteins and Plasma Lipid Transport
    Havel, Richard J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (01) : 9 - 19
  • [39] Triglyceride-rich lipoproteins as agents of innate immunity
    Barcia, AM
    Harris, HW
    CLINICAL INFECTIOUS DISEASES, 2005, 41 : S498 - S503
  • [40] HEPATIC BINDING OF TRIGLYCERIDE-RICH LIPOPROTEINS IN HUMANS
    FLOREN, CH
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (06): : 531 - 537